AR092570A1 - Composicion oral que contiene dapoxetina como base libre - Google Patents

Composicion oral que contiene dapoxetina como base libre

Info

Publication number
AR092570A1
AR092570A1 ARP130103296A ARP130103296A AR092570A1 AR 092570 A1 AR092570 A1 AR 092570A1 AR P130103296 A ARP130103296 A AR P130103296A AR P130103296 A ARP130103296 A AR P130103296A AR 092570 A1 AR092570 A1 AR 092570A1
Authority
AR
Argentina
Prior art keywords
free base
composition containing
oral composition
dapoxetine
containing dapoxetine
Prior art date
Application number
ARP130103296A
Other languages
English (en)
Spanish (es)
Inventor
Jeon Hong
Ryeol - Cha Bong
Geun - Kim Jun
Ki - Park Su
Jun - Lee Bong-Sang
Original Assignee
Ctc Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ctc Bio Inc filed Critical Ctc Bio Inc
Publication of AR092570A1 publication Critical patent/AR092570A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP130103296A 2012-09-13 2013-09-13 Composicion oral que contiene dapoxetina como base libre AR092570A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20120101772 2012-09-13

Publications (1)

Publication Number Publication Date
AR092570A1 true AR092570A1 (es) 2015-04-22

Family

ID=50278454

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130103296A AR092570A1 (es) 2012-09-13 2013-09-13 Composicion oral que contiene dapoxetina como base libre

Country Status (3)

Country Link
AR (1) AR092570A1 (zh)
TW (1) TW201422224A (zh)
WO (1) WO2014042416A1 (zh)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU762934B2 (en) * 1999-09-03 2003-07-10 Allergan Sales, Llc Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
WO2008035358A2 (en) * 2006-06-05 2008-03-27 Cadila Healthcare Limited Process for preparing dapoxetine
WO2008021341A2 (en) * 2006-08-14 2008-02-21 Neurohealing Pharmaceuticals, Inc. Modafinil-based treatment for premature ejaculation
KR20120068678A (ko) * 2010-09-17 2012-06-27 에스케이케미칼주식회사 (ｓ)-ｎ,ｎ-디메틸-3-(나프탈렌-1-일옥시)-1-페닐프로판-1-아민 유도체, 이를 포함하는 약학 조성물 및 이의 제조 방법
WO2012053006A2 (en) * 2010-10-18 2012-04-26 Panacea Biotec Ltd Improved oral fast dissolving films comprising combination of polymers and method of preparation thereof

Also Published As

Publication number Publication date
TW201422224A (zh) 2014-06-16
WO2014042416A1 (ko) 2014-03-20

Similar Documents

Publication Publication Date Title
CL2018001199A1 (es) Composiciones terapéuticas para el tratamiento del virus de inmunodeficiencia humana
FR2959935B1 (fr) Forme pharmaceutique orale alcoolo-resistante
ECSP14013169A (es) Tableta a prueba de alteración que proporciona liberación inmediata del fármaco
GT201500053A (es) Composicion farmaceutica recubierta que contiene regorafenib
JP2013014622A5 (zh)
IT1400982B1 (it) Collirio osmotico trans-epiteliale per la cura del cheratocono.
GT201400012A (es) Compuesto inhibidor de la señalizacion de la trayectoria notch
TWD157919S (zh) 香水瓶
GT201200284A (es) Composición farmacéutica
CL2014001016A1 (es) Compuestos triciclicos condensados y sus sales farmaceuticamente aceptables; composicion farmaceutica que los comprende; y su uso en el tratamiento de una infeccion viral.
AR088297A1 (es) R(+)-n-formil-propargil-aminoindano
GT201200304A (es) Composiciones farmacéuticas que comprenden hidromorfona y naloxona
CO6920289A2 (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib.
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
ECSP15030460A (es) Composición de difenidol de liberación prolongada
CU20140028A7 (es) Compuesto de benzotiazolona
CL2014003484A1 (es) Uso de nalmefeno en la reduccion del consumo de alcohol en un paciente con dependencia del alcohol; composicion farmaceutica oral; combinacion farmaceutica.
PE20151282A1 (es) Combinacion de medicamentos que comprenden fenilefrina y paracetamol
UY33789A (es) Combinación que comprende un derivado de la familia de las combretastatinas y cetuximab
AR092570A1 (es) Composicion oral que contiene dapoxetina como base libre
CL2008003711A1 (es) Proceso para preparar una forma de dosificación farmaceutica que comprende florfenicol o un análogo de este; y para recuperar florfenicol o un análogo de una composición farmacéutica.
CL2014002203A1 (es) Uso de modafinilo en el tratamiento de sustitucion de cocainomanos; composicion farmaceutica oral que contiene modafinilo en la forma de su enantiomero dextrogiro.
EA201590732A1 (ru) Диспергируемая таблетка
PE20141411A1 (es) Nueva forma de cristal
PE20151432A1 (es) Formulaciones de lorazepam de liberacion sostenida

Legal Events

Date Code Title Description
FB Suspension of granting procedure